Zobrazeno 1 - 10 of 65 082 pro vyhledávání: '"hydralazine"'
1
Akademický článek
Comparative efficacy and safety between intravenous labetalol and intravenous hydralazine for hypertensive disorders in pregnancy: A systematic review and meta-analysis of 19 randomized controlled trials.
Autor: Gonçalves OR; Federal University of Piauí, Teresina, Piauí, Brazil. Electronic address: ocilio41@gmail.com., Bendaham LCAR; Federal University of Roraima, Boa Vista, Roraima, Brazil., Simoni GH; Centro Universitário de Várzea Grande Medical School, Várzea Grande, Mato Grosso, Brazil., Kojima GSA; Federal University of Paraná, Curitiba, Paraná, Brazil., Faria HS; Federal University of Santa Maria, Santa Maria, Rio Grande do Sul, Brazil., de Abreu VS; Petrópolis Medical School, Petrópolis, Rio de Janeiro, Brazil., da Silva Júnior AB; Federal University of Piauí, Teresina, Piauí, Brazil., Soares VG; Federal University of Vales do Jequitinhonha e Mucuri, Diamantina, Minas Gerais, Brazil., Ribeiro BL; Federal University of Piauí, Teresina, Piauí, Brazil; New Maternity Dona Evangelina Rosa (NMDER), Teresina, Piauí, Brazil., de Azevedo BB; Federal University of Piauí, Teresina, Piauí, Brazil., de Araújo Melo KCD; Federal University of Piauí, Teresina, Piauí, Brazil; New Maternity Dona Evangelina Rosa (NMDER), Teresina, Piauí, Brazil., de Macedo Lins CD; Federal University of Roraima, Boa Vista, Roraima, Brazil.
Publikováno v: European journal of obstetrics, gynecology, and reproductive biology [Eur J Obstet Gynecol Reprod Biol] 2024 Dec; Vol. 303, pp. 337-344. Date of Electronic Publication: 2024 Nov 04.
Zobrazit plný text záznamu
2
Akademický článek
Two medicinal molecules Hydralazine and Isoniazid have the potential to control wheat crown rot by combing with a N-acetyltransferase FDB2.
Autor: Zhao L; Shandong Provincial Key Laboratory of Biophysics, Institute of Biophysics, Dezhou University, Dezhou, 253023, China. Electronic address: zhaolisdau@163.com., Wang H; College of Agricultural Engineering and Food Science, Shandong University of Technology, Zibo, 255000, China., Cao Z; Shandong Provincial Key Laboratory of Biophysics, Institute of Biophysics, Dezhou University, Dezhou, 253023, China., Li Q; Shandong Provincial Key Laboratory of Biophysics, Institute of Biophysics, Dezhou University, Dezhou, 253023, China., Li Z; Shandong Provincial Key Laboratory of Biophysics, Institute of Biophysics, Dezhou University, Dezhou, 253023, China., Zhao L; College of Physics and Electronic Information, Dezhou University, Dezhou, 253023, China., Liu Y; College of Medicine and Nursing, Dezhou University, Dezhou, 253023, China., Huang Z; Bureau of Agriculture and Rural Affairs of Dezhou City, Shandong Province, Dezhou, 253016, China., Lv E; Shandong Provincial Key Laboratory of Biophysics, Institute of Biophysics, Dezhou University, Dezhou, 253023, China. Electronic address: eglv2018@outlook.com.
Publikováno v: Biochemical and biophysical research communications [Biochem Biophys Res Commun] 2024 Dec 03; Vol. 736, pp. 150893. Date of Electronic Publication: 2024 Oct 24.
Zobrazit plný text záznamu
3
Akademický článek
Synthesis of potent vasodilating agents: in silico and in vitro evaluation of 6-(4-substitutedphenyl)-3-pyridazinone derivatives as potential hydralazine analogues.
Autor: Aziz MW; Pharmaceutical chemistry department, Faculty of Pharmacy, Misr International University, Cairo, Egypt. marian.aziz@miuegypt.edu.eg., Mohamed KO; Pharmaceutical organic chemistry department, Faculty of Pharmacy, Cairo University, Cairo, Egypt.; Pharmaceutical chemistry department, Faculty of Pharmacy, Sinai University (Arish branch), Sinai, Egypt., Farag DB; Pharmaceutical chemistry department, Faculty of Pharmacy, Misr International University, Cairo, Egypt., Khalifa AK; Medical pharmacology department, Faculty of Medicine, Cairo University, Cairo, Egypt.; Medical Pharmacology department, Faculty of Medicine, Nahda University, Beni Suef, Egypt., Mahmoud Z; Pharmaceutical organic chemistry department, Faculty of Pharmacy, Cairo University, Cairo, Egypt. zeinab.mahmoud@pharma.cu.edu.eg.
Publikováno v: Scientific reports [Sci Rep] 2024 Nov 27; Vol. 14 (1), pp. 29514. Date of Electronic Publication: 2024 Nov 27.
Zobrazit plný text záznamu
4
Akademický článek
Effect of Hydralazine on Angiotensin II-Induced Abdominal Aortic Aneurysm in Apolipoprotein E-Deficient Mice.
Autor: Wang, Yutang1 (AUTHOR) owensargisson@students.federation.edu.au, Sargisson, Owen1 (AUTHOR) ngutam372@gmail.com, Nguyen, Dinh Tam1 (AUTHOR) m.wallace@federation.edu.au, Parker, Ketura1 (AUTHOR) s.berzins@federation.edu.au, Pyke, Stephan J. R.1 (AUTHOR), Alramahi, Ahmed1 (AUTHOR), Thihlum, Liam1 (AUTHOR), Fang, Yan1 (AUTHOR), Wallace, Morgan E.1 (AUTHOR), Berzins, Stuart P.1 (AUTHOR), Oqueli, Ernesto2,3 (AUTHOR) ernesto.oqueliflores@bhs.org.au, Magliano, Dianna J.4 (AUTHOR) yutang.wang@federation.edu.au, Golledge, Jonathan5,6 (AUTHOR) jonathan.golledge@jcu.edu.au
Publikováno v: International Journal of Molecular Sciences. Nov2023, Vol. 24 Issue 21, p15955. 13p.
Zobrazit plný text záznamu
5
Akademický článek
Hydralazine use can be associated with IgM-dominated immune complex-mediated glomerulonephritis.
Autor: Zhang PL; Department of Pathology, Corewell Health (East), Royal Oak, MI, USA., Metcalf BD; Department of Pathology, Corewell Health (East), Royal Oak, MI, USA., Khan S; Department of Pathology, Corewell Health (East), Royal Oak, MI, USA., Abukhaled J; Division of Nephrology, Corewell Health (East), Royal Oak, MI, USA., Zafar K; Division of Nephrology, Corewell Health (East), Royal Oak, MI, USA., Li W; Department of Pathology, Corewell Health (East), Royal Oak, MI, USA., Kanaan HD; Department of Pathology, Corewell Health (East), Royal Oak, MI, USA.
Publikováno v: Ultrastructural pathology [Ultrastruct Pathol] 2024 Jul 03; Vol. 48 (4), pp. 317-322. Date of Electronic Publication: 2024 Apr 29.
Zobrazit plný text záznamu
7
Akademický článek
Overlapping drug‐induced vasculitis, ANCA‐associated vasculitis, and lupus nephritis caused by low‐dose hydralazine.
Autor: Bhatnagar, M.1 (AUTHOR), Agaronov, A.2 (AUTHOR), Sarkisyan, E.2 (AUTHOR), Sotoudeh Deilamy, I.1 (AUTHOR), Pepito, D.1 (AUTHOR), Akhondi, H.3 (AUTHOR) hossein.akhondiasl@uhsinc.com
Publikováno v: International Journal of Rheumatic Diseases. Nov2023, Vol. 26 Issue 11, p2272-2277. 6p.
Zobrazit plný text záznamu
8
Akademický článek
INTRAVENOUS LABETALOL VERSUS INTRAVENOUS HYDRALAZINE IN THE MANAGEMENT OF SEVERE PREECLAMPSIA: A RANDOMISED RECIPIENTBLINDED CLINICAL TRIAL.
Autor: Das, Shouvik1 drdasshouvik@gmail.com, Sudrania, Isha2, Mistri, Pallab Kumar3, Somani, Nidhi4
Publikováno v: Indian Obstetrics & Gynaecology. 2022, Vol. 12 Issue 4, p13-18. 6p.
Zobrazit plný text záznamu
9
Akademický článek
The significant improvement in ovarian PCOS syndrome using hydralazine and alendronate aromatase inhibitor FDA-approved drugs in Wistar rat models.
Autor: Kavousipour S; Molecular Medicine Research Center, Hormozgan Health Institute, Hormozgan University of Medical Sciences, Bandar Abbas, Iran., Koohnavard F; Department of Biology, College of Sciences, Shiraz Branch, Islamic Azad University, Shiraz, Iran., Shahbazi B; School of Pharmacy, Semnan University of Medical Sciences, Semnan, Iran., Eftekhar E; Endocrinology and Metabolism Research Center, Hormozgan University of Medical Sciences, Bandar Abbas, Iran. Electronic address: eftekhar19@gmail.com., Ahmadi K; Infectious and Tropical Diseases Research Center, Hormozgan Health Institute, Hormozgan University of Medical Sciences, Bandar Abbas, Iran. Electronic address: Khadijeh_6482@yahoo.com.
Publikováno v: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie [Biomed Pharmacother] 2024 May; Vol. 174, pp. 116504. Date of Electronic Publication: 2024 Mar 29.
Zobrazit plný text záznamu
10
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje